Research programme: infertility therapeutics - Kiadis/OrganonAlternative Names: Reproductive medicine therapeutics - Kiadis/Organon
Latest Information Update: 07 Jul 2007
At a glance
- Originator Kiadis Pharma; Organon
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Infertility
Most Recent Events
- 06 Jul 2007 Discontinued - Preclinical for Infertility in Netherlands (unspecified route)
- 25 May 2005 Preclinical trials in Infertility in Netherlands (unspecified route)